Dr. Ranjana D. Mehta, MD

Dr. Mehta practices at Stony Brook University Hospital in Stony Brook, New York, part of Stony Brook University.

Dr. Mehta's NPI, 1407942147, was assigned on October 4, 2006. Dr. Mehta holds New York license 198176.

Dr. Mehta's primary practice is Stony Brook University Hospital, at Health Sciences Center Suny, Stony Brook, NY 11794 in Suffolk County. The practice phone is (631) 444-4000. Dr. Mehta also practices at Stony Brook University Hospital, 101 Nicolls Rd, Stony Brook, NY 11794.

Dr. Mehta's primary practice is Stony Brook University Hospital in Stony Brook, New York, part of Stony Brook University. Dr. Mehta is also affiliated with Good Samaritan University Hospital St. Charles Campus. The medical group on file is New York Cancer & Blood Specialists. Dmand AI also links Dr. Mehta to 5 more home health agencies, 2 group practices and clinics, 2 medical groups and 1 clinical lab, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehta practices, 10 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Mehta's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Mehta is licensed in New York.

CMS data shows 1,676 Medicare services from Dr. Mehta across 16 procedure codes in 2024, for 440 Medicare patients. Medicare paid $158,432 for them. Every service was in an office.

CMS counts 440 Medicare patients who saw Dr. Mehta in 2024. The largest group is 65 to 74, with 183 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mehta's median patient age at 63, with 56% women.

In 2024, Dr. Mehta wrote 6,552 Medicare Part D claims for 527 patients. 85% of them were for generic drugs. CMS names the drug for 5,738 of them, across 118 drugs with 11 or more claims each, at $737,156 in total drug cost. In 2023, CMS named 5,109 claims across 111 drugs.

Dr. Mehta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mehta as offering telehealth.

CMS Open Payments shows 318 general payments to Dr. Mehta from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,162.